A comprehensive view of Moderna Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Executive Perspective: Moderna CEO says new partnership with OpenAI to play key role as the company works to develop new mRNA medicines; goal is to have employees use ChatGPT no less than 20 times a day
Published:
April 25, 2024
by Gizmodo
|
Moderna To present respiratory & cytomegalovirus research at the ESCMID Global Congress
Published:
April 25, 2024
by Moderna Inc.
|
Moderna partners with OpenAI to integrate generative AI tools into its operations, propelling an AI culture with 80% internal adoption; the enterprise now has more than 750 GPTs driving productivity and automation across the company
Published:
April 24, 2024
by Moderna Inc.
|
Moderna brings Pfizer/BioNTech to court in London claiming patent breach over COVID-19 vaccine technology; Pfizer and BioNTech deny the allegations and call for two Moderna patents to be declared invalid
Published:
April 23, 2024
by AFP World News
|
Moderna signs contract with Brazil's Ministry of Health to supply 12.5 million doses of its mRNA COVID-19 vaccine for the 2024 national vaccination campaign; vaccine delivery expected in Q2 2024
Published:
April 22, 2024
by Moderna Inc.
|
Ask us about our Government & Public Policy market view